6533b82ffe1ef96bd129618e
RESEARCH PRODUCT
“OXXEL (Oxaliplatin plus Xeloda) versus OXAFAFU (Oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis”
Sandomenico CFilippelli GMassidda BPutzu CNatale DMaiorino LCondemi GLeo SGambardella A. Comella P.Sergio Palmerisubject
year | journal | country | edition | language |
---|---|---|---|---|
2006-01-01 |